low ovarian response
Showing 1 - 25 of >10,000
IVF, LOW OVARIAN RESPONSE Trial in Spain (Triptorelin acetate (a-GnRH), Ovitrelle® (hCG), Decapeptyl 0.1 mg® (a-GnRH) and
Recruiting
- IVF
- LOW OVARIAN RESPONSE
- Triptorelin acetate (a-GnRH)
- +2 more
-
Palma De Mallorca, Mallorca, Spain
- +3 more
Apr 4, 2022
Premature Ovarian Insufficiency, Infertility, Female, Sterility, Female Trial in Luebeck (autologous PRP (platelet rich plasma),
Recruiting
- Premature Ovarian Insufficiency
- +3 more
- autologous PRP (platelet rich plasma)
- Saline solution (NaCL) Injection
-
Luebeck, Schleswig-Holstein, GermanyUniversity of Luebeck
Mar 25, 2022
Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))
Not yet recruiting
- Low Grade Serous Ovarian Cancer
- avutometinib + defactinib
- Investigator Choice of Treatment (ICT)
- (no location specified)
Oct 2, 2023
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
Ovarian Cancer Trial in Rome (Tumor biopsy)
Recruiting
- Ovarian Cancer
- Tumor biopsy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023
Platinum-resistant Ovarian Cancer
Not yet recruiting
- Ovarian Cancer
- pegylated liposomal doxorubicin
- (no location specified)
Aug 2, 2023
Poor Ovarian Response Trial in Beijing (Jiajian Guishen granules, coenzyme Q10)
Not yet recruiting
- Poor Ovarian Response
- Jiajian Guishen granules
- coenzyme Q10
-
Beijing, Beijing, China
- +1 more
Oct 18, 2023
Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)
Not yet recruiting
- Ovarian Carcinoma
- PEP-DC1
- +3 more
- (no location specified)
Jan 26, 2023
Low Grade Serous Ovarian Carcinoma and Uterine Involvement :
Completed
- Serous Ovarian Carcinoma
- Low Grade Serous Ovarian Carcinoma
- Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
-
Lyon, FranceHospices civils de Lyon
Feb 14, 2023
Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Biological sample collection
-
Linz, Upper Austria, Austria
- +2 more
Sep 28, 2023
Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)
Not yet recruiting
- Diminished Ovarian Reserve
- Dydrogesterone priming ovarian stiumulation protocol
- GnRH antagonist protocol
- (no location specified)
Apr 26, 2023
Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin
Recruiting
- Carcinoma, Ovarian Epithelial
- Low Grade Serous Adenocarcinoma of Ovary
- Letrozole tablets
- carboplatin AUC 5 and paclitaxel 175 mg/m2
-
Brescia, BS, Italy
- +1 more
Oct 26, 2022
Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)
Recruiting
- Platinum-resistant Epithelial Ovarian Cancer
- Maveropepimut-S
- Cyclophosphamide 50mg
-
Ocala, Florida
- +1 more
Jul 20, 2022
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)
Not yet recruiting
- Ovarian Cancer
- Serous Ovarian Cancer
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Apr 17, 2022
Poor Ovarian Response Trial in Guangzhou (autologous platelet-rich plasma)
Recruiting
- Poor Ovarian Response
- autologous platelet-rich plasma
-
Guangzhou, Guangdong, ChinaReproductive Medicine Research Center, the Sixth Affiliated Hosp
Oct 27, 2022
Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)
Not yet recruiting
- Low Grade Serous Ovarian Carcinoma
- Adult Type Granulosa Cell Tumor
-
Gent, Oost-Vlaanderen, Belgium
- +2 more
May 12, 2023
Patients With Low Grade Ovarian or Peritoneal Tumors
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- +5 more
- Biospecimen Collection
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid
Not yet recruiting
- Recurrent Endometrial Carcinoma
- +8 more
- BET Bromodomain Inhibitor ZEN-3694
- +7 more
- (no location specified)
Jul 15, 2023
Ovarian Tumors, Recurrent Ovarian Carcinoma, Relapsed Ovarian Cancer Trial in Beijing (AK112 low dose, AK112 medium dose, AK112
Terminated
- Ovarian Neoplasms
- +3 more
- AK112 low dose
- +2 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
Oct 8, 2022
Ovarian Cancer Trial in Houston (Shared Medical Decision Tool, Engaging Patients in Decision Making, Literacy Spanish Language)
Recruiting
- Ovarian Cancer
- Shared Medical Decision Tool
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2023
Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
Completed
- Poor Response to Ovulation Induction
-
Barcelona, SpainClinica EUGIN
Jul 20, 2022
Effects of Low LH Serum Levels on Ovarian Pick-up Outcome
Not yet recruiting
- Infertility, Female
- ART
- (no location specified)
Mar 3, 2023
Predictive Value of New AMH Test Method for Ovarian Response
Completed
- Infertility
- AMH
- ELISA
- Chemiluminescence
-
Changsha, Hunan, ChinaReproductive & Genetic Hospital of CITIC-XIANGYA
Jan 11, 2022